The common tumor markers in clinical use are dominant for various tumors, such as carcinoembryonic antigen (CEA) for colorectal cancer, alpha-fetoprotein (AFP) for hepatocellular carcinoma, Ca 12-5 for ovarian cancer, and so forth [6]. This evidence concerns the gene AFP and neoplasm.